BSE filing, NSE: TEJASNET. Summary written from the filing by ALFA Finder's alert engine.
Tejas Networks Ltd: key numbers
- Share price
- ₹412.35
- Market cap
- ₹7,346 Cr
- Revenue (annual)
- ₹1,103 Cr
- Net profit (annual)
- ₹-908.9 Cr
- P/E (TTM)
- -9.0×Sector 57.7×
- Promoter holding
- 53.28%-0.05% QoQ
- FII holding
- 6.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tejas Networks Ltd
All →Tejas Networks Credit Rating
ICRA reaffirmed Tejas Networks' [ICRA]A+(Stable) long-term rating and [ICRA]A1+ short-term rating. The rating covers Rs.6,000 Crore of credit facilities and a Rs.500 Crore CP programme.
Tejas Networks Earnings Call Transcript: Key Takeaways
Tejas reported Q2 FY27 revenue of INR 406 Cr, up 55% YoY, though it posted a PAT loss of INR 207 Cr. Focus remains on BSNL 4G order execution and wireless expansion.
Tejas Networks Other Announcement
Tejas Networks Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Tejas Networks Investor Presentation: Key Takeaways
Tejas reported Q2FY27 revenue of ₹406 Cr, up 55% YoY, but posted a ₹207 Cr net loss. Strategy focuses on BSNL 4G execution and international expansion.
Tejas Networks Results Update
Tejas Networks reported Q2 FY27 financial results, with net revenue of Rs. 406 Crore. The company also highlighted strong demand for its telecom and networking products.
Tejas Networks Q2 FY27 Results: Net Loss of ₹206.9 Cr, Loss Narrows
Tejas Networks Ltd reported revenue from operations of ₹405.7 Cr (+55.0% YoY) and a net loss of ₹206.9 Cr for Q2 FY27.
- Key figure
- Net loss ₹206.9 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date